Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
56.90
-0.79 (-1.37%)
At close: Dec 5, 2025, 4:00 PM EST
56.96
+0.06 (0.11%)
After-hours: Dec 5, 2025, 7:35 PM EST
Nektar Therapeutics Employees
Nektar Therapeutics had 61 employees as of December 31, 2024. The number of employees decreased by 76 or -55.47% compared to the previous year.
Employees
61
Change (1Y)
-76
Growth (1Y)
-55.47%
Revenue / Employee
$1,026,230
Profits / Employee
-$1,979,279
Market Cap
1.16B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NKTR News
- 7 hours ago - Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 23 days ago - Nektar Therapeutics: Balancing The Immune System To Potential Blockbuster Markets - Seeking Alpha
- 24 days ago - Nektar Therapeutics: Cautiously Positive Moving Into Phase 2b Readout - Seeking Alpha
- 27 days ago - New Data from REZOLVE-AD Study of Rezpegaldesleukin Presented in Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting - PRNewsWire
- 4 weeks ago - Nektar Therapeutics (NKTR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Nektar Therapeutics Reports Third Quarter 2025 Financial Results - PRNewsWire
- 5 weeks ago - Nektar Therapeutics to Participate in the Jefferies Global Healthcare Conference in London - PRNewsWire
- 5 weeks ago - Nektar to Announce Financial Results for the Third Quarter on Thursday, November 6, 2025, After Close of U.S.-Based Financial Markets - PRNewsWire